Author

Yael Diesendruck

Institution: Tel Aviv University

Observed institution: Tel Aviv University

OpenAlex ID: A5086493908

Novel immune check point inhibiting antibodies in cancer therapy—Opportunities and challenges

2017 · Yael Diesendruck, Itai Benhar · Drug Resistance Updates · 109

A single-dose F1-based mRNA-LNP vaccine provides protection against the lethal plague bacterium

2023 · Edo Kon, Yinon Levy, et al. · Science Advances · 96

PDF

A key role for IL-13 signaling via the type 2 IL-4 receptor in experimental atopic dermatitis

2020 · Almog Bitton, Shmuel Avlas, et al. · Science Immunology · 86

Targeted lipid nanoparticles for RNA therapeutics and immunomodulation in leukocytes

2020 · Nuphar Veiga, Yael Diesendruck, et al. · Advanced Drug Delivery Reviews · 74

Targeted nanomedicine: Lessons learned and future directions

2023 · Nuphar Veiga, Yael Diesendruck, et al. · Journal of Controlled Release · 68

Dual‐Targeted Lipid Nanotherapeutic Boost for Chemo‐Immunotherapy of Cancer

2022 · Seok‐Beom Yong, Srinivas Ramishetti, et al. · Advanced Materials · 64

Leukocyte-specific siRNA delivery revealing IRF8 as a potential anti-inflammatory target

2019 · Nuphar Veiga, Meir Goldsmith, et al. · Journal of Controlled Release · 59

Delivery of Therapeutic RNA to the Bone Marrow in Multiple Myeloma Using CD38‐Targeted Lipid Nanoparticles

2023 · Dana Tarab‐Ravski, Inbal Hazan‐Halevy, et al. · Advanced Science · 57

PDF

Epithelial cell‐expressed type II IL ‐4 receptor mediates eosinophilic esophagitis

2022 · Shmulik Avlas, Guy Shani, et al. · Allergy · 43

PDF

Autoantibodies to Annexin A2 and cerebral thrombosis: Insights from a mouse model

2021 · Ronen Weiss, Doron Bushi, et al. · Lupus · 7

Eosinophilic Esophagitis Is Critically Mediated By IL-13 Signaling Via IL13Ra1

2022 · Shmuel Avlas, Guy Shany, et al. · Journal of Allergy and Clinical Immunology · 6

Dual‐Targeted Lipid Nanotherapeutic Boost for Chemo‐Immunotherapy of Cancer (Adv. Mater. 13/2022)

2022 · Seok‐Beom Yong, Srinivas Ramishetti, et al. · Advanced Materials · 3

Delivery of Therapeutic RNA to the Bone Marrow in Multiple Myeloma Using CD38‐Targeted Lipid Nanoparticles (Adv. Sci. 21/2023)

2023 · Dana Tarab‐Ravski, Inbal Hazan‐Halevy, et al. · Advanced Science · 2

PDF

An Effective mRNA-LNP Vaccine Against the Lethal Plague Bacterium

2022 · Edo Kon, Yinon Levy, et al. · bioRxiv (Cold Spring Harbor Laboratory) · 2

PDF

Dual-Specific Antibody Design Using Artificial Intelligence

2026 · Michael Peer, Inbar Amit, et al. · bioRxiv (Cold Spring Harbor Laboratory)

PDF

Abstract 438: The multibody drug conjugate (MDC) BD200 mediates anti-tumor activity through a novel dual-targeting mode.

2026 · Michael D. Oberst, Dror Luger, et al. · Cancer Research

Structural modifications of the tumor necrosis factor-α inhibitor Enbrel affect its therapeutic efficacy in a mouse model of rheumatoid arthritis

2026 · Rachel Birnboim-Perach, Adi Aharon, et al. · Journal of Pharmacology and Experimental Therapeutics

PDF

Works count: 17

Citation count: 676

H-index: 9

I10-index: 9